Global Bioactive Materials Market: Snapshot
Owing to the application of bioactive materials in various biomechanical and biochemical purposes, it makes for an evolving market scenario wherein a few players have moderate stronghold. Research and development is at the backbone of the global bioactive materials market, and hence only those players who have economies of scale and proprietorship of latest technologies can lead. Currently, the competition in the bioactive materials market is largely consolidated with Zimmer and Biomet recently joining hands and now holding the lion share. The merger of these two companies in 2015 is expected to have far-reaching consequences on the structure of the bioactive materials market in the near future.
Product differentiation is another vital aspect of the bioactive materials market. Apart from Zimmer Biomet, some of the other key vendors holding notable shares in the global bioactive materials market are Stryker, Kyocera, DePuy Synthes, and Medtronic, and each of these companies hold their market position via different products for targeted segment consumers. Some of the other prominent players in the global bioactive materials market are arthrex, AAP implantate, 3DI, berkeley advanced, baxter (apatech), biomaterials, biomatlante, biocomposites, Ceraver, and CAM Bioceramics.
Request Sample Copy of the Report @
This report contains profiles of most of these companies, aspiring to represent the competitive scenario and the product portfolio of these market leaders. The report also provides quantitative and qualitative estimations of the global bioactive materials market, doing so via proven research methodologies. Various factors that may influence the demand for bioactive materials in the near future and latest trends of the market have also been studied.
Global Bioactive Materials Market: Overview
Bioactive materials provide the appropriate biological response between material and tissue that result in the formation of a bond between them. Bioactive materials are used to manufacture products that have the ability to replace a part of the body in a physiologically safe and economical manner. Moreover, bioactive materials are able to integrate with cells or biological molecules for tissue regeneration. They are also used for the development of bone graft substitutes for bone and joint reconstructive surgeries.
The rising aging population across the world is considered as the primary driver for the global bioactive materials market. The World Health Organization (WHO) estimates that the global geriatric population could increase to as much as 2 bn by the end of 2050. Additionally, the global geriatric population is likely to grow at a very fast rate in developed countries such as the U.S., the U.K., and Japan, over emerging ones. However, the high cost of new technologies and an increased use of synthetic materials in grafting technique are crucial factors that would restrict the global bioactive materials market.
Request TOC of the Report @
Global Bioactive Materials Market: Scope of the Study
There are three primary bioactive materials currently available in the market: polymer-based, metallic-based and ceramic-based bioactive materials. Polymer-based bioactive materials are biodegradable products – natural or synthetic – such as collagen fibrin, hyaluronic acid, and chitosan that can exhibit excellent osteo-conductive and biocompatibility properties. Metallic-based bioactive materials such as titanium and tantalum are widely used for bone and joint reconstructive surgeries due to good corrosion resistance, biocompatibility, and durability. Glass and glass ceramics made from calcium phosphates, calcium sulfates, and bioactive glass are widely utilized as ceramic bioactive materials in medical science.
Global Bioactive Materials Market: Regional Outlook
North America represented the leading regional market for demand volume of bioactive materials, primarily due to the introduction of technologically advanced medical devices and an increase in orthopedic surgeries. The American Academy of Orthopedic Surgeons (AAOS) estimated that, approximately 2.4 mn people in the U.S. would be affected by LSS by 2021. Europe holds second place in this market due to the region’s exceptionally fast-growing geriatric population and increase in life expectancy, as well as a growing prevalence of musculoskeletal diseases. According to the National Healthcare Service (NHS), around 10 mn people in the U.K. have arthritis, out of which 8.5 mn suffer from osteoarthritis.
Read Comprehensive Overview of Report @
Japan and China account for the leading share in the bioactive materials market within Asia Pacific. The Government of Japan stated that it holds the lead in the growth rate of geriatric population in Asia which reached a record of 31.86 mn people in September 2013. The population is expected to reach 95.2 mn by 2050. This significant rise in the geriatric population along with the technological advancement is expected to boost the bioactive materials market in this region. The rest of the world comprises Latin America and The Middle East and Africa. A significant increase in athletic involvement and physical activities has increased the risk of injuries in sports-loving countries such as Brazil and Mexico. The governments of Brazil and Mexico are focusing on reducing overall healthcare expenditure in order to make the surgeries easily accessible at a low cost and thereby enhance the chances of an increase in the uptake of bioactive materials.
Global Bioactive Materials Market: Companies Mentioned in the Report
Major players operating in this market include Baxter International, Inc., Smith & Nephew PLC, CONMED Corporation, DePuy Synthes, Inc., Arthrex, Inc., Medtronic, Inc., Stryker Corporation, and Zimmer Holdings, Inc.